首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Note: Haemophilus influenzae and Moraxella catarrhalis from Patients with Community-Acquired Respiratory Tract Infections: Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada 1997)
【2h】

Note: Haemophilus influenzae and Moraxella catarrhalis from Patients with Community-Acquired Respiratory Tract Infections: Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada 1997)

机译:注意:来自社区获得性呼吸道感染患者的流感嗜血杆菌和卡他莫拉菌:SENTRY抗菌素监测计划的抗菌素敏感性模式(美国和加拿大1997年)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Between February and June of 1997, a large number of community-acquired respiratory tract isolates of Haemophilus influenzae (n = 1,077) and Moraxella catarrhalis (n = 503) from 27 U.S. and 7 Canadian medical centers were characterized as part of the SENTRY Antimicrobial Surveillance Program. Overall prevalences of β-lactamase production were 33.5% in H. influenzae and 92.2% in M. catarrhalis with no differences noted between isolates recovered in the United States and those from Canada. Among a total of 21 different antimicrobial agents tested, including six cephalosporins, a β-lactamase inhibitor combination, three macrolides, tetracycline, trimethoprim-sulfamethoxazole (TMP-SMX), rifampin, chloramphenicol, five fluoroquinolones, and quinupristin-dalfopristin, resistance rates of >5% with H. influenzae were observed only with cefaclor (12.8%) and TMP-SMX (16.2%).
机译:在1997年2月至6月之间,来自SENTRY抗菌监测的一部分是来自27个美国医疗中心和7个加拿大医疗中心的大量社区获得性流感嗜血杆菌(n = 1,077)和卡他莫拉菌(n = 503)呼吸道分离株程序。 β-内酰胺酶生产的总体流行率在流感嗜血杆菌中为33.5%,在卡他莫拉氏菌中为92.2%,在美国和加拿大回收的分离株之间没有差异。在总共测试的21种不同的抗菌剂中,包括6种头孢菌素,一种β-内酰胺酶抑制剂组合,3种大环内酯类,四环素,甲氧苄啶-磺胺甲基恶唑(TMP-SMX),利福平,氯霉素,5种氟喹诺酮和奎奴普丁-达福普汀的耐药率仅头孢克洛(12.8%)和TMP-SMX(16.2%)观察到流感嗜血杆菌> 5%。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号